Accessibility Help

▲ S&P 500 +---%|▲ Stock Advisor +---%Join The Motley Fool

Motley Fool Transcribing

MFTranscribing

Articles by Motley Fool Transcribing — Page 36

Aug 20, 2026 by Motley Fool Transcribing

ATRenew (RERE) Q2 2026 Earnings Call Transcript

Revenue surged 32.4% as 1P business and refurbished devices drove growth.

Aug 20, 2026 by Motley Fool Transcribing

B.O.S. (BOSC) Q2 2026 Earnings Call Transcript

Revenue hit $14.9 million with 29% growth; backlog reached $31 million.

Aug 20, 2026 by Motley Fool Transcribing

PEDEVCO (PED) Q2 2026 Earnings Call Transcript

Revenue surged 561% year-over-year to $46.1 million following the Juniper merger.

Aug 20, 2026 by Motley Fool Transcribing

Co-Dx (CODX) Q2 2026 Earnings Call Transcript

Net loss narrowed to $6.3 million as operating costs fell and FDA submissions advanced.

Aug 20, 2026 by Motley Fool Transcribing

Blaize (BZAI) Q2 2026 Earnings Call Transcript

Revenue guidance cut to $40 million–$43 million as memory costs rise and customer timelines extend.

Aug 20, 2026 by Motley Fool Transcribing

Caliber (CWD) Q2 2026 Earnings Call Transcript

Tokenization and debt refinancing reshape capital formation strategy.

Aug 20, 2026 by Motley Fool Transcribing

Veritone (VERI) Q2 2026 Earnings Call Transcript

VDR revenue surged 71% as management targets breakeven by mid-2027.

Aug 20, 2026 by Motley Fool Transcribing

Afya (AFYA) Q2 2026 Earnings Call Transcript

Medical education revenue grew 7% amid AI competition in clinical tools.

Aug 20, 2026 by Motley Fool Transcribing

AudioEye (AEYE) Q2 2026 Earnings Call Transcript

Revenue hit $10.7 million with 42 straight quarters of growth; EBITDA guidance was raised.

Aug 20, 2026 by Motley Fool Transcribing

Nektar (NKTR) Q2 2026 Earnings Call Transcript

Phase 3 trials for rezpegaldesleukin advance in atopic dermatitis and alopecia areata.

Aug 20, 2026 by Motley Fool Transcribing

StoneCo (STNE) Q2 2026 Earnings Call Transcript

Credit portfolio doubled as management navigates higher rates and defaults.

Aug 20, 2026 by Motley Fool Transcribing

Nu (NU) Q2 2026 Earnings Call Transcript

Net income hit $1.1 billion while customer base grew to 139 million.

Aug 20, 2026 by Motley Fool Transcribing

Volition (VNRX) Q2 2026 Earnings Call Transcript

Revenue flat as cost cuts narrowed losses and cash strengthened.

Aug 20, 2026 by Motley Fool Transcribing

Eton Pharmaceuticals (ETON) Q2 2026 Earnings Call Transcript

Revenue surged 99% year-over-year on HEMANGEOL relaunch and rare disease portfolio growth.

Aug 20, 2026 by Motley Fool Transcribing

TechPrecision (TPCS) Q1 2027 Earnings Call Transcript

Revenue jumped 23% as defense contractor executes turnaround at Stadco subsidiary.

Aug 20, 2026 by Motley Fool Transcribing

Tenon Medical (TNON) Q2 2026 Earnings Call Transcript

Record revenue and gross profit driven by surgical volume and system integration.

Aug 20, 2026 by Motley Fool Transcribing

Grandstand (GRSD) Q2 2026 Earnings Call Transcript

B2B sports data surged 12% as restructuring unlocked $13M in annual savings.

Aug 20, 2026 by Motley Fool Transcribing

PetMed Express (PETS) Q1 2027 Earnings Call Transcript

Management evaluates $3-per-share offer while pursuing partnerships and operational improvements.

Aug 20, 2026 by Motley Fool Transcribing

Cineverse (CNVS) Q1 2027 Earnings Call Transcript

Revenue surged 175% as technology services now drive over 60% of total income.

Aug 20, 2026 by Motley Fool Transcribing

Oxbridge Re (OXBR) Q2 2026 Earnings Call Transcript

Reinsurance tokenization platform SurancePlus raised over $16 million since launch.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services